Levels of Evidence, Quality Assessment, and Risk of Bias: Evaluating the Internal Validity of Primary Research
- PMID: 35903128
- PMCID: PMC9315339
- DOI: 10.3389/fvets.2022.960957
Levels of Evidence, Quality Assessment, and Risk of Bias: Evaluating the Internal Validity of Primary Research
Abstract
Clinical decisions in human and veterinary medicine should be based on the best available evidence. The results of primary research are an important component of that evidence base. Regardless of whether assessing studies for clinical case management, developing clinical practice guidelines, or performing systematic reviews, evidence from primary research should be evaluated for internal validity i.e., whether the results are free from bias (reflect the truth). Three broad approaches to evaluating internal validity are available: evaluating the potential for bias in a body of literature based on the study designs employed (levels of evidence), evaluating whether key study design features associated with the potential for bias were employed (quality assessment), and applying a judgement as to whether design elements of a study were likely to result in biased results given the specific context of the study (risk of bias assessment). The level of evidence framework for assessing internal validity assumes that internal validity can be determined based on the study design alone, and thus makes the strongest assumptions. Risk of bias assessments involve an evaluation of the potential for bias in the context of a specific study, and thus involve the least assumptions about internal validity. Quality assessment sits somewhere between the assumptions of these two. Because risk of bias assessment involves the least assumptions, this approach should be used to assess internal validity where possible. However, risk of bias instruments are not available for all study designs, some clinical questions may be addressed using multiple study designs, and some instruments that include an evaluation of internal validity also include additional components (e.g., evaluation of comprehensiveness of reporting, assessments of feasibility or an evaluation of external validity). Therefore, it may be necessary to embed questions related to risk of bias within existing quality assessment instruments. In this article, we overview the approaches to evaluating internal validity, highlight the current complexities, and propose ideas for approaching assessments of internal validity.
Keywords: bias; confounding; critical appraisal; evidence-based medicine; internal validity; veterinary.
Copyright © 2022 Sargeant, Brennan and O'Connor.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany.GMS Health Technol Assess. 2010 Jun 14;6:Doc07. doi: 10.3205/hta000085. GMS Health Technol Assess. 2010. PMID: 21289880 Free PMC article.
-
Evaluating non-randomised intervention studies.Health Technol Assess. 2003;7(27):iii-x, 1-173. doi: 10.3310/hta7270. Health Technol Assess. 2003. PMID: 14499048 Review.
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
-
Assessing Risk of Bias and Confounding in Observational Studies of Interventions or Exposures: Further Development of the RTI Item Bank [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug. Report No.: 13-EHC106-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug. Report No.: 13-EHC106-EF. PMID: 24006553 Free Books & Documents. Review.
Cited by
-
Advancing herbal medicine: enhancing product quality and safety through robust quality control practices.Front Pharmacol. 2023 Sep 25;14:1265178. doi: 10.3389/fphar.2023.1265178. eCollection 2023. Front Pharmacol. 2023. PMID: 37818188 Free PMC article. Review.
-
Contributing to evidence-based veterinary medicine: A qualitative study of veterinary professionals' views and experiences of client-owned companion animal research.PLoS One. 2025 May 9;20(5):e0322902. doi: 10.1371/journal.pone.0322902. eCollection 2025. PLoS One. 2025. PMID: 40343961 Free PMC article.
-
Prevalence and Factors Associated with Working Equid Lameness in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.Animals (Basel). 2022 Nov 10;12(22):3100. doi: 10.3390/ani12223100. Animals (Basel). 2022. PMID: 36428328 Free PMC article. Review.
-
The digital transformation and future era: bibliometric view of artificial intelligence application in pediatric surgery.Front Pediatr. 2025 Jun 12;13:1528666. doi: 10.3389/fped.2025.1528666. eCollection 2025. Front Pediatr. 2025. PMID: 40574956 Free PMC article.
-
Can the Ability to Recognize Facial Emotions in Individuals With Neurodegenerative Disease be Improved? A Systematic Review and Meta-analysis.Cogn Behav Neurol. 2023 Dec 1;36(4):202-218. doi: 10.1097/WNN.0000000000000348. Cogn Behav Neurol. 2023. PMID: 37410880 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources